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Review
Particulate matter (PM) is a heterogeneous 
mixture varying in physicochemical properties 
depending on meteorological conditions and 
emission sources [World Health Organization 
(WHO) 2006]. Current air quality standards 
for PM use the mass concentration of PM 
[PM with aerodynamic diameters ≤ 10 μm 
(PM10) or ≤ 2.5 μm (PM2.5)] as a metric, 
supported by health studies showing robust 
associations between ambient PM mass con-
centrations and a wide array of adverse health 
effects (WHO 2006). However, it is likely that 
not every PM component is equally important 
in causing these health effects (WHO 2007).
Combustion-related particles are thought 
to be more harmful to health than PM that is 
not generated by combustion (Krzyzanowski 
et al. 2005; WHO 2007). In urban areas, 
road traffic is a major source of combustion 
PM [Health Effects Institute (HEI) 2010]. 
In a systematic review of the literature, 
Krzyzanowski et al. (2005) concluded that 
transport-related air pollution contributes to 
an increased risk of death, particularly from 
cardiopulmonary causes, and that it increases 
the risk of respiratory symptoms and diseases 
that are not related to allergies. In a more 
recent review of traffic-related air pollution, 
HEI (2010) concluded that there was suf-
ficient evidence to support a causal relation-
ship between exposure to traffic-related air 
pollution and exacerbation of asthma, and 
suggestive evidence of a causal relationship 
with onset of childhood asthma, non  asthma 
respiratory symptoms, impaired lung func-
tion, total and cardiovascular mortality, and 
cardiovascular morbidity.
Combustion particles also derive from 
a variety of sources other than motorized 
road traffic, including wood and coal burn-
ing, shipping, and industrial sources, and 
these sources may contribute significantly to 
ambient combustion particle concentrations 
(WHO 2006). There is increasing concern 
that current mass-based PM standards are 
not well suited for characterizing health risks 
of air pollution near sources of combustion 
particles, such as motorized traffic on major 
roads or in wood-smoke–dominated com-
munities. Furthermore, emission reduction 
measures such as the use of particle traps or 
the introduction of environmental zones are 
thought to be effective in reducing exposure to 
traffic-related air pollution, but the estimated 
impact of such measures is relatively small 
when expressed in relation to a reduction in 
the PM mass concentration (Lefebvre et al. 
2011; Millstein and Harley 2010; Tonne et al. 
2008). Nitrogen dioxide (NO2) is a regulated 
component of air pollution that is also used as 
an indicator of traffic-related air pollution in 
health impact assessment and air quality man-
agement (Tonne et al. 2008). However, NO2 
is not a suitable indicator to evaluate the effect 
of traffic abatement measures on exposure to 
combustion particles because some abatement 
measures, such as filters on diesel fueled vehi-
cles, may increase NO2 levels (Millstein and 
Harley 2010). In addition, spatial gradients 
near roadways are less pronounced for NO2 
than for black smoke (BS) and particle num-
ber because of high background concentra-
tions of NO2 (Krzyzanowski et al. 2005). This 
is less of a concern for nitric oxide (NO) and 
nitrogen oxides (NOx), which is the sum of 
NO and NO2, but these components are not 
regulated currently, and they do not appear 
to be toxicologically important at current 
  ambient levels.
These considerations led us to consider 
whether another PM metric might better 
reflect the health effects of combustion-related 
air pollution than PM mass or provide an 
additional indicator of the effectiveness of air 
quality management plans aimed at reduc-
ing exposure to particles from combustion 
sources. We have deliberately used the term 
“additional indicator” because we do not 
claim that all health effects associated with 
PM mass in previous studies can be attributed 
to a marker of combustion particles.
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Ba c k g r o u n d: Current air quality standards for particulate matter (PM) use the PM mass 
  concentration [PM with aerodynamic diameters ≤ 10 μm (PM10) or ≤ 2.5 μm (PM2.5)] as a metric. 
It has been suggested that particles from combustion sources are more relevant to human health than 
are particles from other sources, but the impact of policies directed at reducing PM from combus-
tion processes is usually relatively small when effects are estimated for a reduction in the total mass 
  concentration.
oBjectives: We evaluated the value of black carbon particles (BCP) as an additional indicator in air 
quality management.
Me t h o d s : We performed a systematic review and meta-analysis of health effects of BCP compared 
with PM mass based on data from time-series studies and cohort studies that measured both expo-
sures. We compared the potential health benefits of a hypothetical traffic abatement measure, using 
near-roadway concentration increments of BCP and PM2.5 based on data from prior studies.
re s u l t s: Estimated health effects of a 1-μg/m3 increase in exposure were greater for BCP than for 
PM10 or PM2.5, but estimated effects of an interquartile range increase were similar. Two-pollutant 
models in time-series studies suggested that the effect of BCP was more robust than the effect of 
PM mass. The estimated increase in life expectancy associated with a hypothetical traffic abatement 
measure was four to nine times higher when expressed in BCP compared with an equivalent change 
in PM2.5 mass.
co n c l u s i o n: BCP is a valuable additional air quality indicator to evaluate the health risks of air 
quality dominated by primary combustion particles.
key w o r d s : air quality management, black carbon, combustion particles, health effects, particu-
late matter, review. Environ Health Perspect 119:1691–1699 (2011).  http://dx.doi.org/10.1289/
ehp.1003369 [Online 2 August 2011]Janssen et al.
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Possible candidates for such an indicator 
are measures of black carbon particles [BCP; 
e.g., BS, black carbon (BC), absorption coef-
ficient (Abs), and elemental carbon (EC)] and 
organic carbon (OC), particle number con-
centration, particle surface area, and combus-
tion-specific PM components. The extent of 
available data to support the health relevance 
of these measures varies widely; most of the 
information is available for BS. Evidence is 
also available from both toxicological and 
epidemiological studies of health effects of 
ultrafine PM (Knol et al. 2009), but the costs 
and complexity of monitoring and concerns 
about the validity of central-site monitor-
ing to estimate personal exposure to ultrafine 
particles, which is characterized by particle 
number concentrations rather than particle 
mass, probably limit the feasibility of particle 
number as an additional metric.
A WHO (2003) working group recom-
mended reevaluating BS as an indicator of 
traffic-related air pollution, but a systematic 
comparison using PM versus BCP indicators to 
estimate health effects is still lacking. Grahame 
and Schlesinger (2010) reviewed the evidence 
of effects of BC on cardiovascular health end 
points and concluded that it may be desirable 
to promulgate a BC PM2.5 standard. However, 
no systematic comparison with PM10 or PM2.5 
mass was included. Conversely, Smith et al. 
(2009) noted that although the results of their 
time-series meta-analysis suggest larger effects 
per unit mass of sulfate than of BS; this dis-
tinction was less clear in the few studies that 
directly compared estimated effects of both 
indicators. This observation indicates the need 
to critically compare studies that have meas-
ured PM mass as well as BCP.
BCP would be a useful indicator in addi-
tion to particle mass if a) health risks associated 
with BCP are quantitatively or qualitatively 
different from those associated with PM mass 
on a mass unit basis, b) the spatial contrast 
related to the vicinity of combustion sources 
and the impact of emission reductions is larger 
than for PM mass, and c) BCP and particle 
mass are not—or at least not usually—highly 
correlated in time or space.
In this article we evaluate the value of 
BCP as an indicator of the adverse health 
effects of combustion particles in addition to 
PM mass. We performed a systematic review 
and meta-analysis of epidemiological stud-
ies that measured both PM mass and BCP 
and estimated the potential impact on life 
expectancy of a traffic abatement measure 
using the pooled concentration–response 
functions for BCP and PM2.5. Although we 
focused on traffic-related particles, we refer to 
combustion particles in general because health 
effects estimates were based on measurements 
of BCP from all combustion sources, not 
exclusively traffic.
Materials and Methods
Measurement methods for BCP. BCP as a 
metric of combustion-derived PM may be 
determined by optical methods or thermal-
optical analysis. Optical methods used to 
measure BS, BC, and the Abs of PM are all 
based on the blackness of a filter sample. For 
BS the amount of reflected light is converted 
to total PM mass, whereas for BC it is con-
verted to EC mass. Although BS is expressed 
in micrograms per cubic meter, there is no 
consistent relationship to PM mass because 
conversion of the optical measurement to mass 
units depends on location, season, and type 
of combustion particles (Hoek et al. 1997). 
BS has been used in Europe since the 1920s, 
and although it has been phased out since the 
introduction of PM10 as the new regulatory 
particulate metric, some countries, including 
the Netherlands and the United Kingdom, 
continue to measure BS in selected locations 
(Bloemen et al. 2007). EC is determined by 
thermal-optical analysis in a multistep process, 
typically resulting in a measurement of OC 
as well. There are several different protocols 
to measure EC, and results may differ by up 
to a factor of 2 (HEI 2010). Extreme care is 
thus necessary when comparing data on EC 
from different studies. Concentrations for EC 
averaged over 24 hr are available for regional 
and urban monitoring sites through the U.S. 
IMPROVE (Interagency Monitoring of 
Protected Visual Environments) network and 
the U.S. Environmental Protection Agency 
Chemical Speciation Network, but there are 
no national monitoring networks for EC in 
Europe. Here we use “BCP” as a generic term 
for any of the different metrics (BS, EC, BC, 
or Abs) but refer to the study-specific metric 
when describing individual studies.
The different optical measurements for 
BCP (BS, BC, and Abs) are highly correlated 
(Quincey 2007; Roorda-Knape et al. 1998). 
Although thermally determined EC and 
optical measures of BC are also highly corre-
lated, the quantitative relation between them 
varies between countries, cities, and type of 
location (e.g., regional, urban, traffic), high-
lighting the need for site-specific calibrations 
(Cyrys et al. 2003; Schaap and van der Gon 
2007). Differences between EC measurement 
methods add to this variation. To facilitate 
comparisons among studies that used different 
measures of BCP, we derived a BS-to-EC con-
version factor based on the average increase 
in EC associated with a 10-μg/m3 increase in 
BS reported in 11 studies with information 
on both measures (Adams et al. 2002; Cyrys 
et al. 2003; Edwards et al. 1983; Erdman 
et al. 1993; Janssen et al. 2001; Kinney et al. 
2000; Lena et al. 2002; Schaap and van der 
Gon 2007). Based on this analysis, we assume 
by default that 10 μg/m3 BS is equivalent 
to 1.1 μg/m3 EC [Supplemental Material, 
Table A1 (http://dx.doi.org/10.1289/
ehp.1003369)]. In addition, we conducted 
sensitivity analyses using conversion fac-
tors over the range of the estimates from the 
individual studies (0.5–1.8 μg/m3 EC per 
10 μg/m3 BS).
Systematic review of health effects of BCP 
compared with PM mass. Literature search. 
We conducted a search for peer-reviewed 
literature in PubMed (National Library of 
Medicine 2007) for epidemiological studies 
that evaluated the health effects of (a meas-
ure of) PM mass as well as health effects of 
(a measure of) BCP. We used the following 
key words: (British smoke or black smoke or 
black carbon or elemental carbon or EC or 
soot or absorbance or absorption coefficient) 
AND [particles or particulate matter or par-
ticulates or particulate air pollution or fine 
partic* or “PM10” or “PM2.5” or “PM(2.5)” 
or “PM(10)” or sulfate* or sulphate*] AND 
(mortality or cohort or hospital or emergency).
We scanned all abstracts and retrieved 
papers that potentially included effect estimates 
for PM mass as well as BCP. For acute health 
effects, we considered only time-series stud-
ies on daily mortality and hospital admissions 
or emergency department visits because these 
are generally more similar in design and are 
therefore more likely to allow meta-analyses 
than are studies on, for example, symptoms or 
biomarkers. For health effects due to long-term 
exposure, we considered only cohort studies 
because they have provided the most relevant 
data for setting air pollution standards.
For the time-series studies, we also used 
the Air Pollution Epidemiology Database 
(APED; St George’s, University of London, 
London, UK) to identify suitable studies. This 
database comprises standardized estimates 
extracted from ecological time-series studies 
identified by systematic review that meet cer-
tain quality criteria, with the last retrieval per-
formed on 15 May 2009 (Smith et al. 2009). 
We searched APED for estimates related to 
effects of PM10, PM2.5, PM with aerodynamic 
diameter ≤ 13 (PM13), total suspended par-
ticulates (TSP), or sulfate as well as BS, BC, 
or EC.
We identified 40 papers on time-series 
studies on daily mortality or hospital admis-
sions that included area-specific estimates for 
both PM and BCP, and 17 papers on cohort 
studies. The APED search identified six papers 
that were not identified in the PubMed search, 
but four were excluded because more recent 
estimates from the same city were available. The 
search identified four papers published after the 
last APED systematic review in May 2009.
For the time-series studies on daily mor-
tality and hospital admissions, we excluded 
five papers on TSP because more recent data, 
including effect estimates for PM10, were avail-
able for most of the cities. Also, we excluded Black carbon as additional indicator
Environmental Health Perspectives  •  v o l u m e  119 | n u m b e r 12 | December 2011  1693
one paper on a rare health end point (hospital 
admissions for headache); a total of 34 papers 
were included in the review. All these studies 
had adjusted for major confounders: seasonal-
ity and non  linear function of temperature and 
relative humidity. For the cohort studies, we 
excluded two papers on birth outcomes.
Meta-analysis. For the time-series studies, 
we calculated pooled fixed and random effects 
relative risk (RR) estimates for all health end 
points for which estimates from at least three 
different studies were available for the same 
age group and for different cities. We report 
random effect estimates as significant hetero-
geneity was observed (p < 0.05) among indi-
vidual estimates for some end points. In case 
of no heterogeneity, fixed and random effect 
estimates are similar, so we report random 
effect estimates for all end points for reasons of 
consistency. If estimates for multiple lags were 
reported, we used the estimate discussed by 
the author, as indicated in APED as “selected” 
lag. If multiple risk estimates were available 
from the same city, we only included the most 
recent estimate, and if the study area was part 
of a larger administrative area included in 
another paper (e.g., the Netherlands rather 
than Amsterdam), we included results for the 
larger area only. Finally, we excluded city-
specific estimates for which PM10 was partly 
derived from BS.
We calculated summary fixed and random 
effects estimates using the metan procedure 
in STATA (version 11.2; StataCorp, College 
Station, TX, USA), as described by Harris et al. 
(2008). In order to calculate pooled estimates 
and compare estimated effects for BS and PM 
per mass unit, we converted RRs for BS to RRs 
for EC using the average conversion factor (10 
μg/m3 BS = 1.1 μg/m3 EC) or the range of 
conversion factors from individual studies (i.e., 
0.5–1.8) for sensitivity analysis.
We expressed pooled effect estimates per 
10 μg/m3 (for BS and PM10) or 1 μg/m3 (for 
PM2.5 and EC). To compare effects based on 
comparable contrasts, we calculated the aver-
age ratio of the interquartile ranges (IQRs) 
for PM mass and BCP and compared it with 
the ratio of RR–BCP:RR–PM mass. We 
could not use study-specific IQRs to estimate 
pooled effects because IQRs were not avail-
able for all studies.
Exposure contrast in BCP compared with 
PM mass. We identified studies that simulta-
neously measured PM mass and BCP concen-
trations ≤ 50 m from busy roads (as defined as 
such by the authors) and at background loca-
tions and calculated the ratio between these 
concentrations. To calculate the roadside 
increment (which we define as the difference 
between traffic and background concentra-
tions) for PM2.5 and EC, we averaged meas-
urements at different traffic locations within 
the same study area to derive a single value 
for each study area, and we converted BS and 
Abs concentrations to EC using the 10 μg/m3 
BS to 1.1 μg/m3 EC conversion factor (or 
a range of conversion factors) as described 
above. We then divided the area-specific aver-
age difference between traffic and background 
EC concentrations by the corresponding aver-
age difference between traffic and background 
PM2.5 concentrations to estimate the percent-
age of EC in the roadside increment of PM2.5
Comparison of estimated health benefits 
of traffic abatement measures using PM2.5 or 
BCP. To illustrate the potential implications 
of using BCP as an air quality indicator, we 
estimated the health benefits of a traffic abate-
ment measure for populations living along 
busy roads based on both PM2.5 mass and 
BCP. We used the average and 95% confi-
dence interval (CI) of the percentage EC in 
the roadside increment in PM2.5 (calculated as 
described above) to estimate the health ben-
efits of a hypothetical traffic abatement policy 
measure resulting in a 1-μg/m3 reduction in 
PM2.5 mass. This approach assumes that the 
reduction in BCP resulting from traffic abate-
ment will be proportional to the decrease 
in PM mass by the percentage of EC in the 
roadside increment for PM mass, an assump-
tion that will not hold for all policies.
We estimated the increase in life expec-
tancy that would result from such a traffic 
abatement policy using life table calculations, 
as described by Miller and Hurley (2003), 
for a hypothetical population of 500,000 
people 18–64 years of age, distributed in age 
categories comparable to the 2008 Dutch 
population. We estimated the effects on this 
population for a lifetime.
Results
Health effects of BCP compared with PM mass. 
Studies on BCP and PM10. Most papers con-
cerned time-series studies on PM10 and BS (as 
a measure of BCP) conducted in Europe. We 
present random effects estimates for the per-
cent change in each outcome with a 10-μg/m3 
increase in PM10 or BS in Table 1. Information 
and effect estimates for all individual studies, 
and tests of heterogeneity and fixed effects esti-
mates for studies included in meta-analyses, 
are reported separately for each outcome in 
Supplemental Material, Tables B1–B10 
(http://dx.doi.org/10.1289/ehp.1003369). 
Single-city estimates for the percent change in 
all-cause mortality with a 10-μg/m3 increase 
in BCP and PM10 are also presented in 
Figure 1. Available data were dominated by 
estimates from the APHEA (Air Pollution and 
Health–A European Approach) study (Analitis 
et al. 2006; Atkinson et al. 2001; Katsouyanni 
et al. 2001; Le Tertre et al. 2002). 
For most outcomes, pooled effects esti-
mates for a 10-μg/m3 increase in exposure 
are larger for BS than for PM10, especially 
for mortality and hospital admissions for car-
diovascular causes (Table 1). However, the 
average ratio of the IQRs for PM10:BS [1.7; 
see Supplemental Material, Tables B1–B10 
(http://dx.doi.org/10.1289/ehp.1003369)] 
was consistent with the ratios of RR for 
BS:PM10 (e.g., 0.90/0.60 = 1.5 for cardio-
vascular mortality in Table 1), which suggests 
that effect estimates expressed for a similar 
increase in concentration (IQR) would be 
more or less equivalent. When we used a 
10-to-1.1 conversion factor to transform the 
estimated effect of a 10-μg/m3 increase in BS 
to the estimated effect for a 1-μg/m3 increase 
in EC, the pooled random effect estimate for 
all-cause mortality changed from 0.68% (95% 
CI: 0.31, 1.06) to 0.62% (i.e., 0.68/1.1; 95% 
CI: 0.26, 0.96). When study-specific conver-
sion factors were used, estimated effects for a 
1-μg/m3 increase in EC ranged from 0.38% 
to 1.36% (for conversion factors of 1.8 and 
0.5, respectively), which suggests that the 
effect of a 1-μg/m3 increase in EC on all-cause 
mortality is at least eight times larger than 
Table 1. Summary of pooled random effects estimates for PM10 and BS from time-series studies.
No. of 
estimates




Material table)a End point PM10 BS
Mortality
All causesb 7 0.48 (0.18, 0.79)* 0.68 (0.31, 1.06)* B, D, E, H (B1)
Cardiovascular 7 0.60 (0.23, 0.97)* 0.90 (0.40, 1.41)* A, B, H (B2)
Respiratory 7 0.31 (–0.23, 0.86) 0.95 (–0.31, 2.22) A, B, H (B3)
Hospital admissions
All respiratory (≥ 65 years)c 6 0.70 (0.00, 1.40)* –0.06 (–0.53, 0.41) B, C, G (B4)
Asthma + COPD (≥ 65 years) 5 0.86 (0.03, 1.70)* 0.22 (–0.73, 1.18) C (B5)
Asthma (0–14 years) 5 0.69 (–0.74, 2.14) 1.64 (0.28, 3.02)* B, C (B6)
Asthma (15–64 years) 5 0.77 (–0.05, 1.61) 0.52 (–0.50, 1.55) B, C (B7)
Cardiac (all ages) 4 0.51 (0.04, 0.98)* 1.07 (0.27, 1.89)* B, F (B8)
Cardiac (≥ 65 years) 4 0.67 (0.28, 1.06)* 1.32 (0.28, 2.38)* F (B9)
IHD (≥ 65 years) 5 0.68 (0.01, 1.36)* 1.13 (0.72, 1.54)* B, F (B10)
Abbreviations: COPD, chronic obstructive pulmonary disease; IHD, ischemic heart disease.
aSee Supplemental Material, Tables B1–B10 (http://dx.doi.org/10.1289/ehp.1003369), for specific studies. References: A, 
Analitis et al. (2006); B, Anderson et al. (2001); C, Atkinson et al. (2001); D, Hoek et al. (2000); E, Katsouyanni et al. (2001); 
F, Le Tertre et al. (2002); G, Prescott et al. (1998); H, Zeghnoun et al. (2001). bIncludes cardiovascular and respiratory 
mortality. cIncludes asthma and COPD. *p < 0.05.Janssen et al.
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the estimated effect of a 1-μg/m3 increase in 
PM10 (0.05%).
Studies on BCP and PM2.5. Less, but 
more recent, information was available from 
studies in which both PM2.5 and BCP were 
measured. Three studies provided estimates 
of PM2.5 and EC, both for all-cause mortal-
ity and for cardiovascular mortality. Only 
two studies provided estimates for respira-
tory mortality [Cakmak et al. 2009a; Klemm 
et al. 2004; Mar et al. 2000; Ostro et al. 2007; 
see Supplemental Material, Tables C1–C3 
(http://dx.doi.org/10.1289/ehp.1003369)]. In 
pooled analyses, a 1-μg/m3 increase in PM2.5 
was associated with a 0.19% increase (95% 
CI: 0.03, 0.35%) in all-cause mortality and 
a 0.29% increase (95% CI: 0.07, 0.50%) in 
cardiovascular mortality. For EC, a 1-μg/m3 
increase was associated with a 1.45% increase 
(95% CI: 1.32, 1.57%) in all-cause mortality 
and 1.77% increase (95% CI: 1.08, 3.08%) 
in cardio  vascular mortality. Thus, expressed 
per mass unit, effect estimates are much larger 
(7–8 times) for EC than for PM2.5. However, 
if the ratio of the IQR for PM2.5:EC (~ 11) is 
taken into account, effect estimates were similar.
Available information on the effect of 
PM and EC on hospital admissions or emer-
gency department visits was even more limited 
than for mortality, and no pooled estimates 
could be calculated [Cakmak et al. 2009b; 
Ostro et al. 2009; Peng et al. 2009; Tolbert 
et al. 2007; Zanobetti and Schwartz 2006; 
see Supplemental Material, Table D1 (http://
dx.doi.org/10.1289/ehp.1003369)]. When 
expressed per 1-μg/m3 increase, effect estimates 
were generally 10–30 times higher for EC 
than for PM2.5. However, IQRs for EC were 
lower by a similar factor. For example, the ratio 
of the IQRs for PM2.5:EC from Zanobetti 
and Schwartz (2006) (8.9:1.0) was similar 
to the ratio of the effect estimates for pneu-
monia with a 1-μg/m3 increase in EC:PM2.5 
(0.054:0.0037), suggesting comparable effects 
with a comparable change in exposure.
Two-pollutant models of PM mass and 
BCP. In total, six papers included results of 
two-pollutant models that included a meas-
ure of PM mass as well as BCP. They also 
included findings on mortality as well as hos-
pital admissions and emergency department 
visits (Table 2). With one exception, effect 
estimates for BCP either increased or decreased 
≤ 33% after adjusting for PM mass. In con-
trast, adjusting for BCP substantially reduced 
most effect estimates for PM mass (effect esti-
mates became negative in three of nine studies 
and decreased by > 50% in five of the six other 
studies), suggesting that the effect of BCP is 
more robust than the effect of PM mass.
Studies on BCP and other PM compo-
nents. In addition to the effects of BCP com-
pared with PM mass, the relative health effects 
of BCP compared with other PM components 
are of interest. Specifically, we were interested 
in evaluating whether effects of BCP remained 
significant after the authors had adjusted for 
other potentially relevant components such 
as metals. Eight studies that reported effect 
estimates for EC and PM mass also reported 
estimates for PM components, including OC, 
sulfate, and metals (Cakmak et al. 2009a, 
2009b; Klemm et al. 2004; Mar et al. 2000; 
Ostro et al. 2007, 2009; Peng et al. 2009; 
Sarnat et al. 2008). In general, effects per IQR 
increase in exposure were greater for EC than 
for most of the six other frequently reported 
components [Supplemental Material, Table E1 
(http://dx.doi.org/10.1289/ehp.1003369)]. 
For cardiovascular mortality and morbidity, 
four of five studies reported significant asso-
ciations with an IQR increase in OC, four 
of four reported significant associations with 
potassium, and three of four reported signifi-
cant associations with zinc. Estimated effects 
of an IQR increase in EC on cardiovascular 
mortality and morbidity were significant in 
all five studies. For respiratory mortality and 
morbidity results were more diverse, with the 
strongest effects observed for EC in two stud-
ies (Cakmak et al. 2009a, 2009b) and for OC 
and sulfate in three studies (Ostro et al 2009; 
Peng et al. 2009; Sarnat et al. 2008), and no 
significant (p < 0.05) effects for any of the 
measured components in a sixth study (Ostro 
et al. 2007).
Three studies also reported estimated 
effects based on multipollutant models that 
included a variety of PM components [see 
Supplemental Material, Table E2 (http://
dx.doi.org/10.1289/ehp.1003369)]. Two 
studies conducted in Santiago, Chile, reported 
significant associations with mortality (total, 
cardiac, and respiratory) and hospital admis-
sions (all non  accidental and respiratory) for 
EC, OC, and 10–15 of 16 individual elements 
based on single-pollutant models, but effect 
estimates for only EC and OC remained sig-
nificant after adjustment for all other pollut-
ants measured (Cakmak et al. 2009a, 2009b). 
In a study on emergency department visits 
for cardiovascular and respiratory disease in 
119 U.S. urban communities (Peng et al. 
2009), seven major PM components were 
considered (sulfate, nitrate, silicon, EC, OC, 
sodium ion, and ammonium ion). These seven 
components in aggregate constituted 83% of 
the total PM2.5 mass, whereas all other com-
ponents contributed < 1% individually. In 
single-pollutant models, cardiovascular admis-
sions were significantly associated with same-
day concentrations of five of seven major PM 
components, including EC. In multipollutant 
models with all seven components, only EC 
remained significant. For respiratory admis-
sions, only same-day OC concentrations were 
significant, both in single-pollutant and in 
multipollutant models. In a study of associa-
tions between hospital admissions for cardio-
vascular and respiratory diseases in 106 U.S. 
counties that related admissions to the fraction 
of 20 elements to the total PM2.5 mass rather 
than the concentration, RRs for cardiovascular 
and respiratory hospitalizations were high-
est in counties with high PM2.5 content of 
nickel, vanadium, and EC (Bell et al. 2009). 
Here, nickel was the most robust compo-
nent in multipollutant analyses, especially for 
Figure 1. Single-city, single-pollutant estimates for PM10 and BS and all-cause mortality. Year indicates 
year of publication. References: Amsterdam, 1996 [Verhoeff et al. (1996)]; Amsterdam, 2001 [Roemer and 
van Wijnen (2001a)]; Athens, Barcelona, Birmingham, Cracow, London, and Paris, 2001 [Katsouyanni et al. 
(2001)]; Le Havre, Paris, and Rouen, 2001 [Zeghnoun et al. (2001)]; London, 1999 [Bremner et al. (1999)]; the 
Netherlands, 2000 [Hoek et al. (2000)]; West Midlands, 2001 [Anderson et al. (2001)].
aCities included in the pooled estimate. bZeghnoun et al. (2001). cKatsouyanni et al. (2001).
  Amsterdam, 1996
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cardiovascular admissions. Peng et al. (2009) 
reported statistically significant heterogeneity 
among effect estimates for different PM com-
ponents, with the strongest estimated risk of 
cardiovascular admissions associated with EC 
concentrations. Cakmak et al. (2009a, 2009b) 
also reported that the 95% CI of the estimated 
effect of an IQR increase in EC did not over-
lap the 95% CIs of the other elements, with 
the exception of OC and two or three of the 
other 16 elements, indicating that the effect 
per IQR for EC was significantly greater than 
estimated effects of most other single elements.
Cohort studies on long-term exposure to 
BCP and PM and mortality and morbid-
ity. Cohort studies on mortality. We iden-
tified seven papers that presented results 
from four different cohort studies, two of 
which included effect estimates for BS and 
PM and two for EC and PM (Table 3). 
When using the average conversion factor of 
10 μg/m3 BS = 1.1 μg/m3 EC, RRs for all-cause 
or natural-cause mortality per 1 μg/m3 EC 
in the two European studies and in the study 
by Smith et al. (2009) ranged from 1.05 to 
1.06. RRs for EC and all-cause mortality in the 
veterans study (Lipfert et al. 2006) were about 
three times larger than RRs for the same out-
comes from the other studies, but because the 
standard error in the veterans study was two 
to four times higher compared with the other 
studies, this study contributes less to the pooled 
estimate [RR = 1.06 (95% CI: 1.04, 1.09) per 
μg/m3 EC]. Pooled estimates for a 1-μg/m3 
increase in EC derived using high- and low-end 
conversion factors of 1.8 and 0.5 μg/m3 per 10 
μg/m3 BS were 1.05 and 1.11, respectively. 
When expressed per 1 μg/m3, the RR for EC is 
therefore 7–16 times higher than that of PM2.5 
mass (pooled estimate = 1.007 per 1 μg/m3). 
However, ratios of IQRs for PM2.5:EC for the 
studies by Smith et al. (2009) and Beelen et al. 
(2008) were 14 and 9, respectively, and we 
estimated a ratio of about 5 based on graphi-
cal data presented for the study by Filleul et al. 
(2005). For the study by Lipfert et al. (2006), 
IQRs were not available, but RRs expressed for 
the difference between the mean concentration 
and the minimum were 1.06 per 9.5 μg/m3 for 
PM2.5 and 1.09 per 0.5 μg/m3 for EC. Hence, 
it appears that effect estimates for PM2.5 and 
EC from cohort studies also would be similar 
if expressed for an IQR increase in exposure 
instead of a 1-μg/m3 exposure contrast.
Multipollutant modeling was applied in 
the studies by Lipfert et al. (2006) and Smith 
et al. (2009). Based on four-pollutant models 
that included EC, OC, sulfate, and nitrate, 
Lipfert et al. (2006) concluded that EC had 
the greatest estimated impact on all-cause mor-
tality and that nitrate was the next important 
constituent. In the American Cancer Society 
(ACS) study, Smith et al. (2009) found that 
the EC estimate for all-cause mortality was 
reduced by about 50% and lost statistical sig-
nificance after adjusting for sulfate and ozone. 
For cardiopulmonary mortality, EC decreased 
by about 33% and remained significantly 
associated after adjustment for sulfate but 
decreased by about 80% and lost significance 
after additional adjustment for ozone.
Cohort studies on morbidity. The eight 
papers on respiratory health outcomes in chil-
dren included six papers describing results 
from one Dutch and two German birth 
Table 2. Results from single- and two-pollutant models of time-series studies including PM10 or PM2.5
a and BCP (measured as BS in all studies shown here).
Percent change per 10-μg/m3 increase (95% CI)
PM BS












Bremner et al. 1999 (London) Respiratory mortality NA 1.3 (0.3, 2.3) 0.4 (–1.0, 1.8) 1.9 (0.2, 3.7) 2.0 (–0.4, 4.4)
CVD mortality 0.6 (–0.1, 1.2) 0.2 (–0.6, 1.0) 1.2 (0.1, 2.2) 0.8 (–0.6, 2.2)
Hoek et al. 2000 (the Netherlands) Total mortality 0.77 0.3 (0.0, 0.5) 0.1 (–0.3, 0.6) 0.7 (0.4, 0.9) 0.4 (–0.6, 1.4)
CVD mortality 0.2 (–0.2, 0.5) –0.6 (–1.3, 0.1) 0.8 (0.4, 1.2) 2.1 (0.5, 3.7)
Admissions
Anderson et al. 2001 (West Midlands) Respiratory admissions (all ages) 0.64 0.6 (–0.5, 1.7) “Considerably reduced”d 1.1 (–0.1, 2.2) 2.0 (0.3, 2.8)
Atkinson et al. 1999a (London) A&E visits for asthma; children NA 2.4 (0.7, 4.1) 2.0 (–0.1, 4.2) 2.8 (–0.0, 5.7) 0.9 (–3.0, 5.1)
Atkinson et al. 1999b (London)e Cardiovascular admissions (> 65 years) 0.6–0.7 0.5 (–0.0, 1.0) –0.1 (–0.8, 0.5) 1.9 (0.9, 3.0) 2.3 (0.8, 3.8)
Le Tertre et al. 2002 (APHEA)f Cardiac (all ages) 0.5–0.8 0.5 (0.2, 0.8) –0.2 (–1.2, 0.8) 1.1 (0.4, 1.8) 1.6 (–0.3, 3.5)
Cardiac (> 65 years) 0.7 (0.4, 1.0) 0.1 (–0.4, 0.7) 1.3 (0.4, 2.2) 1.5 (0.3, 2.7)
IHD (> 65 years) 0.8 (0.3, 1.2) 0.2 (–0.9, 1.4) 1.1 (0.7, 1.5) 0.8 (–1.1, 2.7)
Abbreviations: A&E, admission and emergency department; CVD, cardiovascular disease; IHD, ischemic heart disease; NA, not available.
aPM2.5 for Anderson et al. (2001); PM10 for all other studies. bCoefficient of the correlation (R) between PM and BS. cTwo-pollutant models include both PM and BS. dQuantitative infor-
mation not available; paper states that the effect of PM2.5 was considerably reduced when BS was included in the model. eResults only described qualitatively in the paper; quantitative 
estimates provided by the authors on request. fStudy locations were Amsterdam, the Netherlands; Barcelona, Spain; Birmingham, UK; London, UK; and Paris, France.




Reference Cohort Cause PM2.5 EC
Filleul et al. 2005b,c 14,284 adults; age 25–59 years; France 0.87d Natural causese 1.010 (1.004, 1.016) 1.06 (1.03, 1.09)
Cardiopulmonary 1.012 (1.002, 1.023) 1.05 (0.98, 1.11)
Lung cancer 1.000 (0.983, 1.019) 1.03 (0.93, 1.14)
Lipfert et al. 2006 70,000 male U.S. veterans 0.54 All causes 1.006 (0.993, 1.020) 1.18 (1.05, 1.33)
Beelen et al. 2008b 120,852 adults; age 55–69 years; the Netherlands 0.82 Natural causese 1.006 (0.997, 1.015) 1.05 (1.00, 1.10)
Respiratory 1.007 (0.972, 1.043) 1.20 (0.99, 1.45)
Cardiovascular 1.004 (0.990, 1.019) 1.04 (0.95, 1.12)
Lung cancer 1.006 (0.980, 1.033) 1.03 (0.89, 1.18)
Other 1.008 (0.996, 1.021) 1.04 (0.97, 1.11)
Smith et al. 2009 500,000 adults; age 20–87 years; USA NA All causes 1.006 (1.002, 1.010) 1.06 (1.01, 1.11)
Cardiopulmonary 1.012 (1.008, 1.018) 1.11 (1.03, 1.19)
Pooled effect (random)f All causes 1.007 (1.004, 1.009) 1.06 (1.04, 1.09)
NA, not available.
aCoefficient of the correlation (R) between PM and BCP. bRR for EC in European studies estimated from BS as 10 μg/m3 BS = 1.1 μg/m3. cRR for PM2.5 estimated from TSP as PM2.5 = 
0.5 × TSP (Verhoeff et al. 1996; Van der Zee et al. 1998). dFor all 24 sites, whereas RR presented for 18 sites (non  traffic). eInternational Classification of Diseases, 9th Revision (World 
Health Organization 1975), codes < 800. fPooled effect when using 10 μg/m3 BS = 1.8 μg/m3: 1.05 (95% CI: 1.02, 1.07); when using 10 μg/m3 BS = 0.5 μg/m3: 1.11 (95% CI: 1.06, 1.16).Janssen et al.
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cohorts, analyzed using the same exposure 
assessment strategy, and two papers on lung 
function growth in two cohorts of Southern 
California children [Brauer et al. 2002, 2006, 
2007; Gauderman et al. 2002, 2004; Gehring 
et al. 2002; Morgenstern et al. 2007, 2008; 
see Supplemental Material, Tables F1, F2 
(http://dx.doi.org/10.1289/ehp.1003369)]. 
For most of the studies, PM2.5 and BCP were 
highly correlated (R > 0.9). Overall, consistent 
with other types of studies, estimated effects 
of a 1-μg/m3 increase in BCP were greater 
than estimated effects of a 1-μg/m3 increase 
in PM2.5, whereas effects estimated for IQR 
increases were similar for BCP and PM2.5.
Exposure contrast in BCP compared 
with PM mass. Street:background ratios were 
higher and more variable for BCP than for 
PM mass concentrations [Figure 2; see also 
Supplemental Material, Table G1 (http://
dx.doi.org/10.1289/ehp.1003369)]. On aver-
age, BCP concentrations near busy roads were 
twice as high as urban background BCP con-
centrations, whereas PM concentrations near 
busy roads were only about 20% higher than 
background levels. For all single sites, the 
street:background ratio for BCP was higher 
than the corresponding ratio for PM mass. 
For the studies included in Figure 2, the 
average roadside increment of EC relative to 
PM2.5 was 55% (95% CI: 46%, 63%) when 
the conversion 10 μg/m3 BS = 1.1 μg/m3 EC 
was used. Using the lower and upper conver-
sion factors of 0.5 and 1.8 resulted in an aver-
age percentage of 41% (95% CI: 29%, 54%) 
and 70% (95% CI: 59%, 82%), respectively 
[see Supplemental Material, Table G2 (http://
dx.doi.org/10.1289/ehp.1003369)].
Comparison of calculated health bene-
fits of traffic abatement measures using 
PM2.5 or BCP. The estimated percentage 
EC in the roadside increment in PM2.5 of 
40–70% implies that every 1-μg/m3 reduc-
tion in traffic-related PM2.5 along busy roads 
will result in a 0.4- to 0.7-μg/m3 reduction 
in EC. When the average conversion factor of 
10 μg/m3 BS = 1.1 μg/m3 EC is used to derive 
the RR for a 1-μg/m3 increase in EC and the 
percentage of EC in a roadside increment of 
PM2.5, the increase in life expectancy per per-
son is five times higher for EC than for PM2.5 
(3.6 months vs. 21 days; Table 4). When the 
maximum and minimum conversion factors 
of 1.8 and 0.5 μg/m3 EC per 10 μg/m3 BS are 
used, the increase in estimated life expectancy 
is four to nine times higher. Therefore, esti-
mated health benefits are much larger when 
expressed in terms of EC compared with an 
equivalent change in PM mass.
Discussion
Our review shows that health effect esti-
mates from mortality and morbidity time-
series studies as well as cohort studies were 
higher for BCP than for PM10 or PM2.5 
when expressed for a 1-μg/m3 increase in 
exposure and similar when expressed for an 
IQR increase in exposure. A relatively large 
part (40–70%) of the roadside increment in 
PM2.5 mass concentrations can be attributed 
to BCP. Based on the calculated RRs for all-
cause mortality from cohort studies as well 
as the estimated percentage EC in the road-
side increment in PM2.5 mass, the estimated 
increase in life expectancy associated with a 
hypothetical traffic abatement policy meas-
ure was four to nine times higher than when 
expressed per achievable reduction in BCP 
compared with the estimated effect of an 
equivalent reduction in PM2.5 mass.
Health effects of BCP compared with PM 
mass. Single-pollutant effect estimates for daily 
mortality or hospital admissions generally were 
an order of magnitude higher for BCP than for 
PM10 and PM2.5 when expressed per 1 μg/m3. 
When differences in IQRs were accounted 
for, effect estimates were generally similar. It 
should be noted that there was a moderate to 
moderately high correlation between PM10 
and BS measurements reported by the indi-
vidual studies included in the pooled estimates 
(Pearson correlations of 0.5–0.8), consistent 
with correlations between daily wintertime 
PM10 and BS concentrations from a study in 
14 European study areas (Hoek et al. 1997). 
Although this raises concerns about the ability 
to distinguish effects due to PM10 versus BS, 
there is at least some variation in the temporal 
patterns of these exposures.
In studies examining a variety of different 
PM components, BCP generally showed sig-
nificant associations, especially with cardiovas-
cular health end points, both before and after 
adjusting for other components. For cohort 
studies, pooled estimates for all-cause mortal-
ity per 1 μg/m3 were 5–14 times higher for 
BCP than for PM2.5, but IQRs for PM 2.5 were 
higher than those for BCP by a similar factor.
The implication of similar effects per IQR 
is that for policies that reduce all relevant 
components of PM proportional to current 
levels, estimated health benefits would be sim-
ilar based on either indicator. The IQR-based 
comparison is also the relevant comparison 
for health impacts assessments of general air 
quality. However, for assessments of exposure 
conditions dominated by combustion sources, 
or policies directed toward specific combus-
tion sources, the comparison of RRs expressed 
per unit change in mass is relevant.
The available evidence from two-pollutant 
models for time-series studies suggests that the 
effect of BCP is more robust than the effect 
of PM mass. However, two-pollutant models 
with BCP and PM mass were not conducted 
in any of the cohort studies. Although overall 
the results of multipollutant analysis includ-
ing BCP, sulfate, and ozone in the ACS study 
suggest that sulfate has the most robust asso-
ciation with all-cause and cardiopulmonary 
mortality, Smith et al. (2009) indicate that this 
can also be caused by differential amounts of 
measurement error. In the ACS study, where 
exposure was assessed at the metropolitan area 
level, estimates of the spatial distribution of 
EC likely have more measurement error than 
the assigned sulfate exposures because EC is 
more locally generated than is sulfate, which 
is a secondary pollutant with little spatial vari-
ation. When measurement error is present, 
variables measured with high precision will 
tend to dominate model-based predictions rel-
ative to variables measured with less precision 
Table 4. Comparison of the estimated effect on life expectancy of reductions in PM2.5 mass and EC resulting 
from a traffic management plan.
Component Conversion of BS to ECa RRb
Reduction  
[μg/m3 (95% CI)]c
Increase in life expectancy 
per persond
PM2.5 1.007 1.00 21 days
EC 10 μg/m3 BS = 1.1 μg/m3 EC 1.06 0.55 (0.46, 0.63) 3.6 months (3.0, 4.1 months)
10 μg/m3 BS = 1.8 μg/m3 EC 1.05 0.70 (0.59, 0.82) 3.1 months (2.6, 3.6 months)
10 μg/m3 BS = 0.5 μg/m3 EC 1.11 0.41 (0.29, 0.54) 4.5 months (3.2, 5.9 months)
aBS was converted to EC for two of the four studies that were used to calculate the RR for EC and for 8 of 16 studies 
that were used to calculate the percentage EC in the roadside increment of PM2.5 over background. bRR per 1-μg/m3. cA 
traffic abatement measure is evaluated that reduces EC proportional to the percentage EC in the roadside increment of 
PM2.5 over background [Supplemental Material, Table G2 (http://dx.doi.org/10.1289/ehp.1003369)]. dValues in parentheses 
are based on the 95% CI for the reduction.
Figure 2. Study-specific street:background ratios 
for PM mass and BCP concentrations. Blue, ≥ 24-hr 
average along highways; green, ≥ 24-hr average 
along inner-city roads; red, daytime and ≤ 12-hr 
measurements (all inner-city roads). Data from 
Boogaard et al. (2011), Cyrys et al. (2003), Fischer 
et al. (2000), Fromme et al. (2005), Funasaka et al. 
(2000), Harrison et al. (2004), Janssen et al. (1997, 
2001, 2008), Kinney et al. (2000), Lena et al. (2002), 
Riediker et al. (2003), Roemer and van Wijnen 
(2001b), Roorda-Knape et al. (1998), Roosli et al. 
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(Smith et al. 2009). For time-series studies, 
there are no large differences in temporal rela-
tionships between central-site ambient con-
centrations and personal exposure for BCP 
and PM2.5 (Janssen et al. 2005). In addition, 
issues related to the correlation between dif-
ferent pollutants and the extent to which they 
can act as surrogates for the etiologic agent(s) 
complicate the interpretation of results from 
multipollutant models (Tolbert et al. 2007). 
Our interpretation that the results from two-
pollutant models for the time-series studies 
suggest that BCP is a more health–relevant 
indicator in these studies than is PM mass is 
also supported by Roemer and van Wijnen 
(2001a, 2002), who calculated separate effect 
estimates with separate exposure estimates 
using background and traffic-influenced meas-
urement stations and for the total population 
and people living along busy roads. Effect esti-
mates for urban background BS were larger 
in the population living along busy roads 
than for the total population, suggesting that 
this subpopulation was more highly exposed. 
Indeed, effect estimates for the population 
living along busy roads using BS measured at 
traffic stations were more or less equivalent to 
effect estimates for the total population using 
BS measured at urban background stations.
Further evidence of health effects of pri-
mary combustion is obtained in studies that 
use source apportionment techniques to 
assess associations of particles from different 
sources with health. Particles from traffic or 
local combustion were associated with daily 
mortality and hospital admissions (Cakmak 
et al. 2009a, 2009b; Laden et al. 2000; Mar 
et al. 2000; Sarnat et al. 2008). Although 
measures of BCP are not frequently used in 
human controlled exposure studies, several 
human exposure studies using exposure to 
diesel exhaust have documented airway and 
systemic inflammation (Salvi et al. 2000), 
as well as responses that provide a possible 
mechanism for cardiac events such as myo-
cardial infarction (Mills et al. 2007). Two 
studies illustrated the importance of particle 
composition: Mills et al. (2008) found little 
effect of 2-hr exposure to high PM2.5 con-
centrations taken in Edinburgh, attributed to 
the high sea salt content (90%); Urch et al. 
(2005) found blood pressure increases in 
healthy subjects related to the OC content of 
fine PM—largely from motorized traffic—but 
not to total PM2.5.
Spatial contrast in BCP compared with 
PM2.5. Higher street:background ratios 
for BCP compared with PM (Figure 2) are 
consistent with the larger impact of traffic 
on BCP than on PM mass concentrations. 
However, the studies included in our review 
represent a variety of settings, including dif-
ferent distances to the roadside, traffic densi-
ties (including vehicle types), averaging times, 
seasons, and meteorological conditions. These 
factors probably (partly) explain the variability 
in ratios observed between studies.
The impact of traffic on BCP was also 
demonstrated for temporal concentration 
variations by Schaap and van der Gon (2007), 
who showed that BS levels on rural and urban 
locations in the Netherlands were about 50% 
higher on weekdays than on Sundays, whereas 
BS concentrations at urban traffic locations 
were about 100% higher on weekdays than on 
Sundays. Comparison of weekdays and Sundays 
for PM10 mass concentrations showed much 
smaller differences (5–15%). We estimated 
that, on average, 55% of the roadside increment 
in PM2.5 consisted of EC based on absolute dif-
ferences in concentrations between street and 
background concentrations. Deriving an overall 
quantitative estimate of this percentage across 
studies is complicated by the different measure-
ment methods used for BCP, in which differ-
ences between methods for measuring EC and 
differences in conversion of optical measures 
of BCP to EC concentrations both need to be 
taken into account. We therefore converted BS 
and Abs to EC using a conversion factor based 
on the average of 11 identified area-specific 
comparison studies and used the range of these 
11 values in sensitivity analyses.
Our estimates compare well with previous 
studies (Lefebvre et al. 2011; Lena et al. 2002; 
Millstein and Harley 2010). In a study on 
the spatial variation in EC and PM2.5 in rela-
tion to local truck-traffic density, Lena et al. 
(2002) estimated that EC represents 52% of 
the total PM2.5 generated by large trucks. In 
comparison, in a modeling study on the effects 
of retrofitting trucks with diesel particle fil-
ters, EC accounted for 64% of total diesel 
PM2.5 emissions (Millstein and Harley 2010). 
Similarly, in a modeling study of the effect of 
a speed limit reduction on traffic-related EC, 
Lefebvre et al. (2011) estimated that EC traffic 
emissions account for 70% of the total PM2.5 
exhaust emissions. These figures are also in 
the range provided by the European emission 
inventory guidebook for the EC fraction in 
PM2.5 in exhaust emissions for different vehi-
cle categories (e.g., passenger cars, vans, and 
trucks) (Ntziachristos and Samaras 2009). The 
contribution of BCP in roadside increments of 
PM10 will be smaller because resuspended road 
dust, including brake and tire wear, results in a 
more substantial contribution to PM10 (Gietl 
et al. 2010; Janssen et al. 1997).
Comparison of calculated health benefits 
of traffic abatement measures using PM2.5 or 
BCP. We evaluated the gain in life expectancy 
of a 1-μg/m3 decrease in PM2.5 and 0.55 μg/m3 
EC, based upon the average contribution of EC 
to the increment in PM concentration in stud-
ies comparing a major road and urban back-
ground. This calculation can be interpreted as 
an indication of the potential difference in a 
health impact assessment based upon PM2.5 or 
BCP for populations living along a major road. 
It can also be interpreted as the potential health 
gain for policies that reduce concentrations in 
approximately the same ratio as the current 
roadside increment, for example, a limitation 
of overall traffic intensity.
There are few empirical data to support 
larger impacts of policies on BCP than on 
PM2.5 mass. In an evaluation of the effects of 
retrofitting trucks with diesel engine particle 
filters on air quality in Southern California, 
Millstein and Harley (2010), using an Eulerian 
photochemical air quality model, estimated 
a decrease in EC concentrations in 2014 of 
12–14%. The estimated effect on PM2.5 mass 
concentrations was much smaller (< 1%). In 
a modeling study of the effect of a speed limit 
reduction (from 120 to 90 km/hr) on air qual-
ity in Flanders, EC concentrations decreased up 
to 30% just next to the busiest highways, com-
pared with an estimated reduction of at most 
8.5% for PM2.5. For buffer zones of 0–100 m 
distance to the highways EC concentrations 
decreased by 9–10% (Lefebvre et al. 2011). A 
small monitoring study on the effects of road 
closures associated with the 2004 Democratic 
National Convention in Boston suggested 
slightly lower concentrations of EC and NO2 
during the road closure periods at monitoring 
sites proximate to the closed highway segments. 
This decrease was not observed for PM2.5 or far-
ther from major highways (Levy et al. 2006).
Our finding of a larger increase in life 
expectancy associated with a hypothetical traf-
fic abatement policy measure when expressed 
per achievable reduction in BCP than when 
expressed per an equivalent amount of PM2.5 
mass illustrates that health effects of such poli-
cies may be seriously underestimated when 
based upon PM2.5 or PM10. As an illustration, 
we calculated the increase in life expectancy 
for the population living along major roads. 
We did not attempt to calculate the impact 
for the larger population. However, although 
the absolute improvement of air quality will 
be smaller, we expect that the differences 
between BCP and PM mass will be similar. In 
a modeling study of the effect of a speed limit 
reduction, Lefebvre et al. (2011) estimated a 
decrease in EC concentrations of 0.4 μg/m3 
for buffer zones within 200 m of the high-
ways, affecting about 75,000 inhabitants if the 
abatement measure would be implemented on 
all highways in Flanders and Brussels. For the 
buffer zone within 1,500 m of the highway 
the reduction was smaller, 0.17 μg/m3 (5%), 
but affecting up to 1.8 million inhabitants.
Overall discussion. Our review shows that 
BC is associated with health effects that are 
not reflected quantitatively in the same way 
by particle mass, as indicated by the higher 
effect estimates per 1 μg/m3 for BCP com-
pared with PM mass.Janssen et al.
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In the reviewed studies, ambient meas-
urements of various BCP metrics were used. 
Although motorized traffic was an important 
source of BC in most of these studies, they 
included the impact of all combustion sources 
on BCP concentrations, including coal and 
wood burning, shipping emissions, and indus-
trial sources. In a review of source apportion-
ment studies for fine PM EC, Schauer (2003) 
found that the combined contribution of 
diesel- and gasoline-powered vehicles ranged 
from 74% to 98%; the contribution from 
biomass burning ranged from 0.7% to 25%; 
and the contribution from other sources, from 
0.5% to 17%. The derived risks therefore rep-
resent those for BCP as a general indicator 
of combustion particles, not exclusively traf-
fic. Issues therefore remain when these risk 
estimates are applied to specific combustion 
sources such as traffic or wood burning. We 
however hold that BCP more closely resem-
bles the harmful components in these air pol-
lution mixtures than does general PM2.5.
Associations between individual elements 
and mortality or morbidity could be explained 
by the health effects of that element or the 
health effects of a pollution mixture of which 
the element is an indicator. Therefore, BCP 
could be serving as an indicator for the larger 
category of primary combustion particles, 
which, in addition to BCP, can include trace 
metals and hydrocarbons such as polycyclic 
aromatic hydrocarbons, any or all of which 
could be acting to cause adverse health effects. 
Our analysis assumes that these other compo-
nents are equally decreased relative to reduc-
tions in BCP when measures are taken that 
reduce emissions of combustion particles. This 
assumption will be more valid for meas  ures 
that do not affect engine characteristics, such 
as a restriction of the number of vehicles, com-
pared with measures that affect particle com-
position, such as speed reduction or changes 
in engine types or fuel mixtures. Furthermore, 
because BCP is a marker for tailpipe emissions, 
it is less suitable to evaluate the health benefits 
of traffic-oriented abatement measures that are 
expected to result in reductions in non  tailpipe 
emissions, from brake linings, crank cases, tire 
wear, and so forth, which may be uncorrelated 
with reductions in BCP.
In 2003, a WHO working group rec-
ommended reevaluation of BS as part of 
the reconsideration of the WHO air quality 
guidelines and consideration of the addition 
of photometric analysis of BCP on the PM2.5 
filters (WHO 2003). Our review supports this 
recommendation. We foresee application of a 
BCP indicator in evaluation of current levels 
of traffic-related air pollution, wood smoke, 
or other combustion particles and policies 
aimed at reducing these sources. Of the dif-
ferent methods to measure BCP, probably the 
best method would be EC measurements using 
standard methodology (Cavalli et al. 2010). 
However, it is beyond the scope of this article 
to make recommendations about the methods 
that should be used to measure BCP.
In summary, we do not promote BCP as 
an alternative marker for PM mass because 
this would disregard the effects of coarse 
particles or particles from other sources. 
Nonetheless, our review shows that BCP is a 
valuable additional air quality indicator that 
would be particularly useful to evaluate health 
risks of air pollution dominated by primary 
combustion emissions, as well as benefits of 
traffic abatement measures.
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